Did You Know...
...that the Band-Aid Bandage was invented by a Johnson & Johnson employee whose wife had cut herself? Earl Dickson's wife was rather accident prone, so he set out to develop a bandage that she could apply without help. He placed a small piece of gauze in the center of a small piece of surgical tape, and what we know today as the Band Aid bandage was born!
PatentStorm News
Make the Most of PatentStorm
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest patents by subscribing to an RSS feed.
Got questions? Ask a Patent Expert!
Registered users: Manage your profile, comments and alerts.
| Number | Title | Issue Date |
| 7442721 | Durable biocompatible controlled drug release polymeric coatings for medical devices Disclosed herein are biocompatible durable controlled drug releasing polymeric coatings for medical devices. The drug release rates of the polymers are controlled by adjusting monomer ratios and glass transition temperatures Tgs. The polymers are durable; they do no... | 10/28/2008 |
| 7429619 | Polyacrylic film forming compositions Water soluble, gelatin-free dip coatings for substrates comprising an acrylic film former; a paraben plasticizer; and a secondary plasticizer such as polyvinylpyrrolidone, polyethylene glycol 300, polyethylene glycol 400 or mixtures thereof. ... | 09/30/2008 |
| 7419685 | Process for producing solid dosage forms Solid dosage forms containing at least one polymer binder, at least one active ingredient and, where appropriate, conventional additives, wherein a physiologically tolerated, water-swellable graft copolymer or a mixture of graft copolymers is employed as polymeric b... | 09/02/2008 |
| 7388032 | Sustained release compositions, process for producing the same and utilization thereof A sustained-release composition containing a hydroxynaphthoic acid salt of a biologically active substance and a biodegradable polymer, a method of its production, and a pharmaceutical composition containing said sustained-release composition. ... | 06/17/2008 |
| 7374778 | Enhanced transport using membrane disruptive agents Compositions and methods for transport or release of therapeutic and diagnostic agents or metabolites or other analytes from cells, compartments within cells, or through cell layers or barriers are described. The compositions include a membrane barrier transport enh... | 05/20/2008 |
| 7342047 | Crosslinkable hydrophilic materials from reactive oligomers having pendent unsaturated groups The present invention provides cross linkable compositions useful in the preparation of hydrophilic gels, and are prepared from obligers having pendent hydrophilic ploy(alkenylene oxide) groups, and pendent pulverizable functional groups, and cross linked by polyfun... | 03/11/2008 |
| 7314636 | Biodegradable injectable implants containing glycolic acid This invention is directed to the field of medical implants, and more specifically to biodegradable injectable implants and their methods of manufacture and use. The injectable implants disclosed herein comprise glycolic acid and bio-compatible/bio-absorbable polyme... | 01/01/2008 |
| 7288265 | Treating viral infection at smallpox vaccination site An adhesive patch is provided wherein the patch includes a porous backing having a front side and a back side. The patch also includes a therapeutic formulation located on the front side of the backing. The backing includes a flexible sheet of water insoluble porous... | 10/30/2007 |
| 7265157 | Sustained release compositions, process for producing the same and use thereof Sustained release compositions containing a physiologically active substance or its salt, hydroxynaphthoic acid or its salt and a lactic acid-glycolic polymer or its salt, wherein the product of the weight-average molecular weight of the lactic acid-glycolic acid po... | 09/04/2007 |
| 7265117 | Topical brimonidine tartrate formulations that lack chlorine dioxide Topical solution compositions of brimonidine tartrate are disclosed. The solution compositions lack an oxidative preservative. ... | 09/04/2007 |
| 7262222 | Synergistic mixtures of o-phenylphenol and other nitrogen and aldehyde microbiocides Ortho phenylphenol or its sodium salt is shown to form synergistic antimicrobial mixtures with nitrogen and aldehyde-containing microbiocides. ... | 08/28/2007 |
| 7255870 | Composition containing a semicrystalline polymer, uses thereof, and method for making A composition containing an aqueous phase dispersed in an oily phase, at least one emulsifier with an HLB value ranging from 1 to 8, at least one organic powder, and, in the oily phase at least one semicrystalline polymer with organic structure that is solid at room... | 08/14/2007 |
| 7244703 | Pharmaceutical compositions and methods for peptide treatment Compositions and methods for treating a patient with a pharmaceutically active peptide that combines a pharmaceutically active peptide, a permeation enhancer, and a carrier, are disclosed. ... | 07/17/2007 |
| 7189414 | Controlled release oral drug delivery system The invention relates to synchronous drug delivery composition comprising a polymeric matrix which comprises hydrogel blended with a hydrophobic polymer, so as to form an erodible matrix, a drug, and, optionally, an agent which enhances intestinal drug absorption an... | 03/13/2007 |
| 7163397 | Apparatus for applying material for selectively modifying the optical properties of metabolically different cells An apparatus for applying a viscous modification material includes a material source of the modification material and a needle connected to the source. A material for selectively modifying the optical properties of cells comprises a basic material and a modification... | 01/16/2007 |
| 7147864 | Methods for preventing photodamaged skin by administering selegiline or desmethylselegiline The present invention is directed to methods that can be used in the treatment of wounds, burns, and photodamaged skin. Methods can be used for both humans and animals and involve the administration of compositions containing selegiline and/or desmethylselegiline. | 12/12/2006 |
| 7144584 | S(+) desmethylselegiline and its use to treat narcolepsy The present invention provides novel compositions and methods for using the S(+) enantiomer of desmethylselegiline (N-methyl-N-(prop-2-ynyl)-2-aminophenylpropane), for the treatment of selegiline-responsive diseases and conditions. Diseases and conditions responsive... | 12/05/2006 |
| 7125546 | Polymeric micelle containing cisplatin enclosed therein and use thereof Provided is a complex comprising cisplatin encapsulated therein in a form in which a chlorine ion thereof is ligand-exchanged with a carboxyl anion of a block copolymer comprising poly(ethylene glycol)-poly(glutamic acid). This complex can be a medicinal preparation... | 10/24/2006 |
| 7118761 | Method for producing a silver-containing wound care device Wound care devices having a topically applied silver-based antimicrobial finish are provided. The finish comprises at least one silver ion-containing compound and at least one binder compound. The finish may be applied to a target substrate, such as a fiber, fabric,... | 10/10/2006 |
| 7115707 | Amino acid sequences capable of facilitating penetration across a biological barrier This invention relates to novel pharmaceutical penetration compositions capable of facilitating penetration of at least one effector across biological barriers. The invention also relates to methods of treating or preventing diseases by administering penetration com... | 10/03/2006 |
| 7112561 | Pharmaceutical compositions and methods for insulin treatment Compositions and methods for treating a patient with insulin that combines insulin, a permeation enhancer, and a carrier that maintains an acidic pH, are disclosed. ... | 09/26/2006 |
| 7112559 | Thickened quaternary ammonium compound sanitizer The invention pertains to a thickened rinseless hand sanitizer composition comprising a quaternary ammonium compound. The invention also pertains to a method of applying to the skin of a human a thickened rinseless hand sanitizer composition that comprises a quatern... | 09/26/2006 |
| 7101840 | Polymeric drug formulations A method of forming a polymeric drug formulation in which a water-soluble drug is blended with a water-insoluble tissue-compatible polymer that is miscible in the solid phase with the drug, and with a poly(alkylene oxide), in a solvent system capable of forming a ho... | 09/05/2006 |
| 7094421 | Plaster containing 4-biphenylacetic acid It is provided the plaster of anti-inflammatory and analgesic, improving the sustained releasing of 4-biphenylacetic acid from the base adhesive material and low skin irritation, by using more than two kinds of resolvent for 4-biphenylacetic acid having low solubili... | 08/22/2006 |
| 7056972 | Composition containing stimuli-responsive polymer, ink composition containing it, and image-forming method and apparatus using the ink composition The present invention relates to a stimuli-responsive composition that contains a polymer, a solvent and a substance having a predetermined function. One embodiment of the composition contains a block polymer, a solvent and a substance having a predetermined functio... | 06/06/2006 |
| 7030985 | Colored transparent or translucent cosmetic composition The invention relates to a transparent or translucent colored cosmetic composition for making up the skin, lips and superficial body growths comprising a transparent or translucent cosmetic base and at least one coloring agent in an amount such that the transmission... | 04/18/2006 |
| 7025992 | Pharmaceutical formulations The invention relates to pharmaceutical formulations for use in the administration of lipophilic medicaments via mucosal surfaces. In particular the invention provides pharmaceutical formulations for use in administration of a lipophilic medicament via a mucosal sur... | 04/11/2006 |
| 7011844 | Formulations for the administration of fluoxetine Composition of matter for application to a body surface or membrane to administer fluoxetine by permeation through the body surface or membrane, the composition comprising fluoxetine to be administered, at a therapeutically effective rate, alone or in combination wi... | 03/14/2006 |
| 6998128 | Controlled release composite A composite is disclosed having a controlled rate of dissolution. The composite includes (a) a first region that includes a first composition that includes calcium sulfate, the first region exhibiting a first rate of dissolution; and (b) a second region that include... | 02/14/2006 |
| 6998110 | Buccal, polar and non-polar spray or capsule Buccal aerosol sprays or capsule using polar and non-polar solvent have now been developed which provide biologically active compounds for rapid absorption through the oral mucosa, resulting in fast onset of effect. The buccal polar compositions of the invention com... | 02/14/2006 |
| 6977070 | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system Buccal aerosol sprays or capsules using polar and non-polar solvent have now been developed which provide biologically active compounds for rapid absorption through the oral mucosa, resulting in fast onset of effect. The buccal polar compositions of the invention co... | 12/20/2005 |
| 6969508 | Buccal, polar and non-polar spray or capsule containing drugs for treating pain Buccal aerosol sprays or capsules using polar and non-polar solvent have now been developed which provide biologically active compounds for rapid absorption through the oral mucosa, resulting in fast onset of effect. The buccal polar compositions of the invention co... | 11/29/2005 |
| 6967023 | Pharmaceutical and cosmetic carrier or composition for topical application A pharmaceutical or cosmetic carrier or composition for topical application characterized by rheological properties which render the carrier or composition semi-solid at rest and a liquid upon application of shear forces thereto. The composition or carrier are prepa... | 11/22/2005 |
| 6953587 | Process for making a water-soluble foam component The present invention relates to a process for preparing a water-soluble foam matrix which is capable of delivering an active ingredient and articles of manufacture comprising said foam matrix, said article comprising: i) a water-s... | 10/11/2005 |
| 6911209 | Method of treating sick sinus syndrome with levosimendan Levosimendan, or (−)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]propanedinitrile, which has been previously suggested for the treatment of congestive heart failure is useful in the treatment of sick sinus syndrome and/or sinoatrial condu... | 06/28/2005 |
| 6890522 | Cosmetic and personal care compositions Cosmetic or personal care compositions, such as for styling hair, comprise a thermoplastic elastomer which is a block copolymer comprising a core polymer having a backbone comprising at least a proportion of C—C bonds and two or more flanking polymers. Each flanki... | 05/10/2005 |
| 6866860 | Cationic alkyd polyesters for medical applications The present invention is directed to medical devices or pharmaceutical composition, each containing a synthetic, biodegradable, biocompatible polymer that is the reaction product of a polybasic acid or derivative thereof, a monoglyceride, and a cationic polyol. ... | 03/15/2005 |
| 6867181 | Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides A method of spherifying a sustained release ionic conjugate which contains a free carboxyl group-containing polymer and a free amino group-containing drug which are ionically bonded to each other. ... | 03/15/2005 |
| 6858673 | Composition for hydrogel, hydrogel and use thereof A composition for hydrogels which comprises (A1) a copolymer which comprises 25 to 97 mol % of unit (a) derived from a compound represented by formula (1) and 3 to 75 mol % of unit (b) derived from a monomer represented by formula (2) and is soluble in aqueous media... | 02/22/2005 |
| 6825234 | Compositions and methods for amelioration of human female sexual dysfunction The invention provides compositions and methods suitable for ameliorating female sexual dysfunction, and in particular, female sexual arousal disorder. In one embodiment, the invention provides a semisolid composition suitable for topical application comprising: an ... | 11/30/2004 |